A growing concern among parents is increasing as more children return to school out without protection of a Covid-19 vaccination for at least a few more months is a source of concern. It’s understandable that parents are worried about their children. After months of decreasing instances, the virus is now targeting those who have not been inoculated. Vaccination against Covid-19 is now available to adolescents as early as 12 years of age, but younger children are not eligible for the vaccine at this time. For the week ending August 26, children accounted for almost a quarter of all reported cases. According to the American Academy of Pediatrics, the numbers have “grown rapidly,” reaching levels that have not been seen in the United States since the winter of last year.

Taking A Long Time To Administer Covid Vaccination To Kids Than Adults?

Despite the fact that children have been largely spared the worst effects of Covid-19, hospitalizations and fatalities among children are more common than among adults, despite the fact that children’s hospitals have been filling up in Covid-19 hotspots throughout the nation. The introduction of a children’s vaccination cannot come soon enough, yet the procedure is taking longer than some had anticipated.

Taking A Long Time To Administer Covid Vaccination To Kids Than Adults

Covid-19 vaccinations for younger children are currently undergoing clinical trials, and data is still being collected. Once the vaccine makers have obtained the findings of their trials, they will need to submit the information to the United States Food and Drug Administration, which will evaluate the vaccinations and determine whether or not they should be approved. During an appearance on CBS’ Face the Nation on Sunday, Dr. Scott Gottlieb now serves on the board of directors of Covid-19 vaccine manufacturer Pfizer, said the company would likely be able to file the data for 5-11-year-olds for permission “at some point in September” and afterward file the application for emergency use of the vaccine “possibly as early as October.”

Once a business files a request to the FDA, there is no set timeline for when the request will be processed. It may take many weeks to complete emergency usage considerations. Doctor Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, responded to Wolf Blitzer on CNN’s Wolf Blitzer on Wednesday by saying that he hopes a Covid-19 vaccine will be approved for young children before Thanksgiving, but that he does not want to get ahead of the Food and Drug Administration.

Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention, said at a National Parent Teacher Association town hall on Wednesday that she is optimistic that the Pfizer vaccine would be accessible for children by 2021. In the event that school is not safe: ‘You feel as if you are putting your kid into the mouth of a lion.’ The statistics for 2-to-5-year-olds may be released shortly after the data for older children. Pfizer told CNN that it expects to have enough research completed by October or November for the youngest children and that it would petition the FDA to approve emergency use of the medication soon after. Moderna’sstudy is now ongoing, although it will be completed a few months after Pfizer’s. Johnson & Johnson does not plan to begin its numerous pediatric studies until the autumn, at the very earliest.